Nordwand Advisors LLC bought a new position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 70,580 shares of the company’s stock, valued at approximately $5,260,000.
Other large investors also recently bought and sold shares of the company. Rothschild Investment LLC increased its position in shares of Corteva by 8.7% in the second quarter. Rothschild Investment LLC now owns 5,768 shares of the company’s stock valued at $430,000 after buying an additional 462 shares in the last quarter. PAX Financial Group LLC increased its holdings in Corteva by 5.9% during the 2nd quarter. PAX Financial Group LLC now owns 3,646 shares of the company’s stock valued at $272,000 after acquiring an additional 202 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH increased its holdings in Corteva by 5.2% during the 2nd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 516,823 shares of the company’s stock valued at $38,519,000 after acquiring an additional 25,573 shares in the last quarter. Rockefeller Capital Management L.P. raised its position in Corteva by 34.0% during the second quarter. Rockefeller Capital Management L.P. now owns 62,648 shares of the company’s stock worth $4,669,000 after acquiring an additional 15,891 shares during the last quarter. Finally, Kingsview Wealth Management LLC lifted its holdings in shares of Corteva by 34.2% in the second quarter. Kingsview Wealth Management LLC now owns 13,989 shares of the company’s stock valued at $1,043,000 after purchasing an additional 3,566 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.
Insider Buying and Selling at Corteva
In other news, EVP Robert D. King sold 37,280 shares of the stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $74.20, for a total transaction of $2,766,176.00. Following the transaction, the executive vice president directly owned 49,262 shares in the company, valued at $3,655,240.40. This represents a 43.08% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.15% of the stock is currently owned by insiders.
Corteva Trading Down 3.1%
Corteva (NYSE:CTVA – Get Free Report) last announced its quarterly earnings data on Tuesday, November 4th. The company reported ($0.23) EPS for the quarter, beating analysts’ consensus estimates of ($0.49) by $0.26. The business had revenue of $2.62 billion during the quarter, compared to the consensus estimate of $2.47 billion. Corteva had a return on equity of 9.37% and a net margin of 9.19%.The business’s revenue for the quarter was up 6.5% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.49) earnings per share. Analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.
Corteva Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Monday, December 1st will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, December 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.1%. Corteva’s dividend payout ratio is currently 30.77%.
Analysts Set New Price Targets
A number of research analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Corteva from $90.00 to $85.00 and set a “buy” rating for the company in a research note on Thursday, November 6th. Wells Fargo & Company lowered their target price on Corteva from $80.00 to $77.00 and set an “overweight” rating on the stock in a report on Tuesday, November 11th. Barclays raised Corteva from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $75.00 to $84.00 in a report on Wednesday, August 13th. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 30th. Finally, Royal Bank Of Canada dropped their price objective on Corteva from $86.00 to $80.00 and set an “outperform” rating for the company in a research report on Friday, October 17th. Fifteen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and an average target price of $78.39.
Get Our Latest Analysis on CTVA
About Corteva
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Further Reading
- Five stocks we like better than Corteva
- What Makes a Stock a Good Dividend Stock?
- Whirlpool’s Worst May Be Over—Upside Opportunity Ahead
- With Risk Tolerance, One Size Does Not Fit All
- These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
